Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
Fifteen haemophiliac patients acquired antibodies to human T-lymphotropic virus type III during 1984. One batch of factor VIII concentrate given to all these patients is presumed to be the cause of the seroconversion. A further eighteen patients who received the same batch did not seroconvert and one other patient became seropositive but had not received this batch. Before transfusion of the implicated batch the patients had low T-helper-cell numbers and T-helper/suppressor ratios; neither changed in those who seroconverted. The probability of seroconversion was independently related to the pre-existing low T-helper/suppressor ratio, the number of vials of the implicated batch transfused, and the total annual factor VIII consumption. Ten other patients received a batch of factor IX concentrate from the same donor plasma; none of these patients seroconverted.
Ludlam
C A
CA
Tucker
J
J
Steel
C M
CM
Tedder
R S
RS
Cheingsong-Popov
R
R
Weiss
R A
RA
McClelland
D B
DB
Philp
I
I
Prescott
R J
RJ
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission*; D000914:Antibodies, Viral; D017977:Deltaretrovirus / Q000276:immunology*; D004340:Drug Contamination; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D012192:Retroviridae Infections / Q000276:immunology*; D012698:Serologic Tests; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000914:Antibodies, Viral; D005169:Factor VIII